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ICP4Viral microRNAs regulate gene expression using either translational repression or mRNA cleavage and decay.
Two microRNAs from infectious laryngotracheitis virus (ILTV), iltv-miR-I5 and iltv-miR-I6, map antisense to
the ICP4 gene. Post-transcriptional repression by these microRNAs was tested against a portion of the ICP4
coding sequence cloned downstream of ﬁreﬂy luciferase. Luciferase activity was downregulated by
approximately 60% with the iltv-miR-I5 mimic. Addition of an iltv-miR-I5 antagomiR or mutagenesis of the
target seed sequence alleviated this effect. The iltv-miR-I5 mimic, when co-transfected with a plasmid
expressing ICP4, reduced ICP4 transcript levels by approximately 50%, and inhibition was relieved by an iltv-
miR-I5 antagomiR. In infected cells, iltv-miR-I5 mediated cleavage at the canonical site, as indicated by
modiﬁed RACE analysis. Thus, in this system, iltv-miR-I5 decreased ILTV ICP4 mRNA levels via transcript
cleavage and degradation. Downregulation of ICP4 could impact the balance between the lytic and latent
states of the virus in vivo.aware Biotechnology Institute,
. Fax: +1 302 831 4054.
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MicroRNAs are small, non-coding RNAs found in plant, animal, and
viral genomes. These molecules are considered important contribu-
tors to regulation of cellular processes because of their widespread
and diverse tissue- and condition-speciﬁc expression proﬁles (He and
Hannon, 2004) and because they can regulate at least 60% of
vertebrate transcripts (Friedman et al., 2009). MicroRNAs are
generally thought to function in animal cells by base-pairing to their
target mRNAs, which leads to translational inhibition or mRNA
degradation (Bartel, 2004; Filipowicz et al., 2008; Nilsen, 2007).
Complementarity between nucleotides 2 and 7/8 of the microRNA
(known as the “seed” sequence) is crucial for target recognition in
mRNA destabilization, translational repression, or both, and 100%
complementarity is important for RNA-induced silencing complex
(RISC)-mediated cleavage (Bartel, 2009). Some microRNAs act as
small interfering RNAs (siRNAs) through an RNAi mechanism via
100% complementarity to their targets (Wang et al., 2004). A number
of viruses, herpesviruses in particular, encode microRNAs (Cullen,
2006; Pfeffer et al., 2005). Because of the compact nature of viralgenomes, many viral microRNAs are derived from non-coding
transcripts antisense to functional genes. However, regardless of
genomic address, viral microRNAs can act via an siRNA mechanism
(Barth et al., 2008; Seo et al., 2008, 2009; Sullivan et al., 2005; Tang
et al., 2008, 2009) or via imperfect base pairing to targets, as with
animal microRNAs (Grey et al., 2007; Murphy et al., 2008; Umbach
et al., 2008).
Herpesviruses, which are characterized by latent infections, are
likely to use microRNAs to enhance viral effects on host cells, and this
can be accomplished by regulating either host or viral genes (Cullen,
2009). Epstein-Barr virus (EBV) (Pfeffer et al., 2004), Kaposi's
sarcoma-associated herpesvirus (KSHV) (Cai et al., 2005), human
herpes simplex virus 1 (HSV1) (Umbach et al., 2008), murine
herpesvirus 68 (MHV68) (Pfeffer et al., 2005), human cytomegalovi-
rus (HCMV) (Grey et al., 2005), Marek's disease virus 1 (MDV1)
(Burnside et al., 2006; Yao et al., 2008), MDV2 (Waidner et al., 2009;
Yao et al., 2007), herpesvirus of turkeys (HVT) (Waidner et al., 2009),
and infectious laryngotracheitis virus (ILTV) (Waidner et al., 2009) are
among the herpesviruses known to encode microRNAs. Some viral
microRNAs are expressed during latency and therefore may be
important in regulating the balance between productive and latent
viral states. For instance, microRNAs of MDV1 (Burnside et al., 2006),
MDV2 (Waidner et al., 2009; Yao et al., 2007), EBV (Grundhoff et al.,
2006; Pfeffer et al., 2004), KSHV (Cai et al., 2005; Grundhoff et al.,
26 L.A. Waidner et al. / Virology 411 (2011) 25–312006; Pfeffer et al., 2005; Samols et al., 2005), HSV1 (Umbach et al.,
2008), Rhesus monkey rhadinovirus (RRV) (Schafer et al., 2007), and
murine herpesvirus 68 (MHV68) (Pfeffer et al., 2005) are predomi-
nantly clustered at one or two sites in the genome, and one of the
clusters lies in a region active during latency. In some cases,
microRNAs are antisense to sequences within (Waidner et al., 2009;
Yao et al., 2007) or in the vicinity of (Burnside et al., 2006; Yao et al.,
2008) the immediate early gene, ICP4.
Many viral microRNAs map antisense to viral lytic genes, but the
mechanism of downregulation of the antisense targets varies among
andwithin viruses. Viral microRNAs that are highly complementary to
their targets may regulate them at the mRNA level, at the protein
level, or not at all. MicroRNA-mediated cleavage is used in regulation
of the large T-antigen mRNA in two human polyomaviruses (JC and
BK) (Seo et al., 2008) andmurine polyoma virus (Sullivan et al., 2009).
Additionally, HSV2-miR-H3 is 100% complementary to the neuro-
virulence factor gene ICP34.5 and downregulates it in an siRNA-like
manner (Tang et al., 2008). In contrast, translation inhibition is used
by HSV1-miR-H2, which maps antisense to the immediate-early
transactivator ICP0 gene (Umbach et al., 2008). In HCMV, miR-112-1
has high complementarity (15/22 nucleotide match) to the immedi-
ate early gene IE1 but does not affect mRNA levels even though it does
decrease IE1 protein expression (Grey et al., 2007; Murphy et al.,
2008). HSV miRs H3 and H4 are 100% complementary to ICP34.5, but
regulation of this transcript by these microRNAs has not been
addressed (Umbach et al., 2008). However, HSV miR-H6 shows
extensive seed complementarity to the HSV ICP4 and does down-
regulate expression of ICP4 (Umbach et al., 2008).
ILTV is an alphaherpesvirus belonging to the genus Iltoviridae. It
has a general genome structure that resembles that of HSV, but unlike
most alpha-herpesviruses, it does not contain the repeat regions
ﬂanking the unique long genome segment (I/TRL). ILTV causes a
respiratory disease in chickens and pheasants, with the severity of the
disease varying from decreased egg production to conjunctivitis and
severe tracheal infections resulting in bloody expectoration (Bagust
et al., 2000; Garcia and Riblet, 2001; Kirkpatrick et al., 2006). In
addition, after a short acute infection phase of 2 weeks or less, the
virus becomes latent in the central nervous system (Williams et al.,
1992) and can subsequently reactivate, resulting in re-infection of
exposed ﬂocks (Hughes et al., 1989; Hughes et al., 1991). The most
abundant microRNAs from ILTV, iltv-miR-I5 and iltv-miR-I6, map
antisense to the ICP4 gene (Rachamadugu et al., 2009; Waidner et al.,
2009), which is located in the internal and terminal repeats ﬂanking
the unique short genome segment (I/TRS). ICP4 is a major transcrip-
tional regulator that is essential for viral growth; it is an immediate-
early gene that is repressed during latency. In the study presented
here, we investigate whether iltv-miR-I5 could downregulate the
immediate early gene ICP4.
Results
iltv-miR-I5 reduced expression from reporter plasmids containing
complementary sites
The action of iltv-miR-I5 and iltv-miR-I6 on the expression of ILTV
ICP4 was tested using luciferase reporter assays. A 409-bp fragment
from the coding region of ICP4, corresponding to nucleotides
115,017–115,425 in the IRS (146,290–146,708 in the TRS), was cloned
downstream of the luciferase gene in the pMIR-REPORT™ vector
(pMiR-Report-I5-I6-target, Fig. 1, inset). This portion of the IPC4 open
reading frame contains sequences that are 100% complementary to
iltv-miR-I5 and iltv-miR-I6. Plasmid pMiR-Report-I5-I6-target was co-
transfected into COS7 cells along with mimics and antagomiRs.
Transfections included the pMIR-REPORT™ β-galactosidase plasmid
to evaluate transfection efﬁciency, and relative luciferase activity was
determined (Fig. 2). The addition of the iltv-miR-I5 mimic resulted insigniﬁcant repression (pb0.05), with approximately 60% reduction in
luciferase activity compared to control samples (Fig. 2A). Repression
of luciferase activity was observed for the iltv-miR-I6 mimic but was
not signiﬁcant (23% reduction, p=0.072). Samples co-transfected
with a combination of mimics for iltv-miR-I5 and iltv-miR-I6 showed
a level of luciferase repression similar to that seen with iltv-miR-I5
alone (Fig. 2A), and this was also signiﬁcantly lower than the negative
control (pb0.05).
To conﬁrm the speciﬁcity of the negative regulatory effect of iltv-
miR-I5, we mutated three nucleotides in the seed target region for
iltv-miR-I5 in plasmid pMiR-Report-I5-I6-target (Fig. 2B). The iltv-
miR-I5 mimic signiﬁcantly reduced expression of the wild-type target
construct by approximately 60% and was signiﬁcantly different from
the control (pb0.05, Fig. 2C), and the addition of an antagomiR of miR-
I5 alleviated this effect (p=0.49). Co-transfection of the iltv-miR-I5
mimic with the mutated construct did not result in a signiﬁcant
reduction (15% reduction, p=0.21, Fig. 2C). As expected, the co-
transfection with the mutant construct along with the iltv-miR-I5 and
its antagomiR did not differ signiﬁcantly from the control transfection
(p=0.11).
In order to assess whether physiological levels of ILTV-derived
miR-I5 could downregulate ICP4, iltv-miR-I5 target luciferase con-
structs were transfected into LMH cells infected with ILTV. The timing
of ILTV growth and microRNA expression was ﬁrst tested in this cell
culture system with an ILTV multiplicity of infection (MOI) of 2.2
(Supplemental Fig. 1). A qPCR based on quantiﬁcation of the gC gene
was used to measure total viral genomes per well. In this system, the
number of ILTV genomes per well was maximal at 35–50 h post-
infection (hpi) (Supplemental Fig. 1A). In addition, iltv-miR-I5 was
measured by Northern analysis, and microRNA accumulation was
detected as early as 19 hpi (Supplemental Fig. 1B) but was higher at
later times (28 and 50 hpi). A 331-bp fragment containing the iltv-
miR-I5 target region in the coding region of ICP4 (nucleotides
146,391–146,708 in the TRS) was cloned downstream of the luciferase
gene in the pMIR-REPORT™ vector (pMiR-Report-I5-target, Fig. 1,
inset). Luciferase constructs WT pMiR-Report I5-target, its mutated
derivative, or the empty vector pMIR-REPORT™ were transfected at
36.5 to 49.5hpi. At 4.5 to 9 h post-transfection, cells were assayed for
normalized luciferase values. In numerous experiments, both wild-
type and mutated target constructs were expressed at lower levels
compared to expression in cells transfected with empty vector pMIR-
REPORT™ (data not shown). This ﬁnding was unexpected but
reproducible, and it could indicate that a cellular microRNA or even
another regulatory mechanism can target ILTV ICP4 independent of
iltv-miR-I5.
The experimental protocol was modiﬁed such that the cell culture
medium was not removed during the transfection process in order to
allowmaximum accumulation of virus and virus-encodedmicroRNAs.
Data from the two experiments done with this modiﬁed protocol are
shown in Fig. 3. Both wild-type and mutated targets were expressed
at lower levels compared to expression in cells transfected with
empty vector. In mock-infected cells, there was no signiﬁcant
difference between the wild-type and mutant reporter constructs. In
the ILTV-infected cells, there was a slightly lower expression (16–17%
difference) of the wild-type compared to the mutant reporter (Fig. 3),
and the value obtained from the wild-type transfection was
signiﬁcantly lower than that of the mutated construct in both
experiments (pb0.05). However, the effect was not large, the
experimental protocol was delicate to optimize, and the assay was
complicated by the background reduction of reporter expression in
mock-infected cells.
iltv-miR-I5 reduced ICP4 mRNA levels by transcript cleavage
Since iltv-miR-I5 is 100% complementary to the coding region of
ICP4, we hypothesized that this microRNA could act as an siRNA and
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in LMH cells co-transfected with a plasmid construct expressing ICP4
(pRc-ICP4) (Fuchs et al., 2000) along with microRNA mimics and
antagomiRs (Fig. 4). Total RNA was subjected to quantitative RT-PCR
(qRT-PCR) using a primer pair designed to amplify the region of the
ICP4 coding region that contains the putative binding site for iltv-miR-
I5 (5T-F and 5T-R; Supplemental Fig. 2A). All ICP4 RT-PCR reactions
were normalized to cellular GAPDH. Transfection of iltv-miR-I5
resulted in approximately 50% reduction in RNA levels compared to
the control, and this reduction was signiﬁcant (pb0.01). Transfection
with iltv-miR-I5 plus its antagomiR alleviated this effect. The iltv-miR-
I6 mimic did not result in apparent reduction of ICP4 mRNA in this
assay (Supplemental Fig. 2B). When primers ﬂanking an area
downstream of the potential target regions for iltv-miR-I5 and miR-
I6 were used, no signiﬁcant downregulation was observed in
treatments containing microRNA mimics miR-I5 or miR-I6 (Supple-
mental Fig. 2). These data are consistent with the idea that the area
downstream of the putative microRNA cleavage site is protected from
degradation after cleavage (Llave et al., 2002).
To verify that the cleavage products were generated speciﬁcally by
iltv-miR-I5, a modiﬁed RACE procedure that captures endonuclease-
generated mRNA fragments with 5′ phosphorylated ends, which are
suitable for ligation with T4 RNA ligase (Franco-Zorrilla et al., 2007;
German et al., 2008; Llave et al., 2002), was used for locating the cleavage
sites. Primary and secondary RACE ampliﬁcationswere expected to result
in267and212-bpamplicons, respectively, since the reverseRACEprimers
(Supplementary Table 1)map to those genomic locations downstream of
the predicted cleavage site for iltv-miR-I5 (genome position 146,630). To
test the RACE procedure, we ﬁrst prepared RNA from COS7 cells co-
transfected with pRc-ICP4 and either the iltv-miR-I5 mimic or with the
negative control mimic (negative control mimics from Ambion, Inc., #
AM17110). RACE amplicons of the expected size, indicating the adapter
was ligated to the predicted cleavage site at nucleotide #11 of themicroRNA, were observed in the sample transfected with the iltv-miR-I5
mimic, but no product was seen in the negative control mimic sample
(data not shown). To establish that iltv-miR-I5 acts as an siRNA in an ILTV
infection, theRACEprocedurewas repeatedonRNAsamples isolated from
ITLV-infected LMH cells. The ICP4 cleavage products were cloned and
sequenced (Fig. 5). Eighteen clones were sequenced, and six clones
mapped to the region of ICP4 surrounding the presumed binding site for
iltv-miR-I5 (Fig. 5). For four of those six, sequence analysis indicated that
the cleavage site was between nucleotides #10 and 11 of the iltv-miR-I5
binding site (Fig. 5). Two clones mapped nearby, but outside of the iltv-
miR-I5 binding site, 13 and 28 nucleotides upstream of iltv-miR-I5. The
remaining 12 clones all mapped to the open reading frame of UL45 at
genomeposition24,259or24,245, near the ILTVoriginof replication (data
not shown).
Discussion
This study demonstrates that an ILTVmicroRNA that is antisense to
the major transcriptional activator ICP4 has the potential to act as an
siRNA and direct cleavage of the ICP4 transcript. Using luciferase
reporters and qRT-PCR, iltv-miR-I5 repressed ICP4 by about 50%,
whereas iltv-miR-I6 was less effective. The mutation of three
nucleotides within the iltv-miR-I5 seed recognition sequence re-
moved the effect of iltv-miR-I5 on luciferase activity. In addition, a
modiﬁed RACE procedure validated that cleavage could occur within
the predicted binding site.
Herpesvirus microRNAs appear to be related to latency associated
transcript (LAT) expression and/or processing. Indeed, iltv-miR-I5 and
iltv-miR-I6 could even be derived from processing of the putative ILTV
LAT (Johnson et al., 1995). In the case of MDV1, the LAT transcript is
antisense to ICP4 and generally shows inverse levels of expression
with this gene (Cantello et al., 1994; Cantello et al., 1997).
Transcription from the MDV1 LAT region is complex, and microRNAs
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et al., 2006; Morgan et al., 2001), suggesting that LAT-derived
microRNAs could play a role in maintaining latency or controlling
the balance between productive and latent viral states. Although
some studies indicate that the LAT has no effect on latency in HSV 1
(Block et al., 1990; Ho andMocarski, 1988; Sedarati et al., 1989), other
studies indicate that it is important in the establishment of latency
(Perng et al., 2000; Sawtell, 1997), and improper splicing of the LAT
affects the reactivation kinetics of HSV1 in neuronal tissues (Kang
et al., 2003). The HSV1 LAT encodes numerous microRNAs, some of
which are expressed during latency, suggesting that LAT-derived
microRNAs are important in the lytic/latent balance of HSV1 (Jurak
et al., 2010; Umbach et al., 2008). Understanding the relationship
between herpesvirus microRNAs and LATs is likely to be a key to
discovering regulatory details that dictate host–virus interactions.
In general, when microRNAs mediate mRNA target cleavage,
perfect complementarity between the microRNA and its target exists
(Bartel, 2004; Friedman et al., 2009). This mechanism is typically used
in plants but can also occur in animals. The Bartel laboratory reported
the cloning of a mouse HOXB8 mRNA fragment containing near-
perfect complementarity to miR-196, with cleavage between the
tenth and eleventh nucleotides of the microRNA (Yekta et al., 2004). A
number of herpesviruses encode microRNAs that show 100%complementarity with viral genes and regulate gene expression by
an siRNA-like mechanism (Barth et al., 2008; Seo et al., 2008, 2009;
Sullivan et al., 2005; Tang et al., 2008; Tang et al., 2009). There are
exceptions to this, as many microRNAs lie antisense to and are exactly
complementary to their targets but do not direct cleavage of the
putative mRNA targets. For example, the HCMV uracil DNA glycosy-
lase protein activity is downregulated by miR-UL112-1 (Stern-
Ginossar et al., 2009), but the mRNA apparently is not cleaved by
this microRNA (Grey et al., 2008). Other studies of virally encoded
microRNAs suggest that those antisense to viral genes do not always
participate in mRNA degradation in the experimental systems used
(Murphy et al., 2008; Umbach et al., 2008), and multiple mechanisms
may exist for viral microRNA action.
In our study, iltv-miR-I5 was more effective than iltv-miR-I6 at
downregulating ICP4, although both are antisense to ICP4. In chicken
embryo kidney cells (CEK) infected with ILTV (4 h post-infection),
iltv-miR-I5 was the most abundant viral microRNA (Waidner et al.,
2009). However, in LMH or CEK cells 3 days post-infection, the
dominant ILTVmicroRNAwas iltv-miR-I6 (Rachamadugu et al., 2009).
Thus, the levels of expression of different microRNAs could vary with
the viral replicative cycle, although a side-by-side evaluation of the
expression kinetics of these microRNAs has not been made. Even if
iltv-miR-I5 and iltv-miR-I6 were derived from the same transcript,
Fig. 3.Wild-type and mutated luciferase constructs transfected into ILTV-infected LMH
cells. In two experiments, LMH cells were infected with ILTV at an MOI of 0.22
(Experiment 1) or 0.16 (Experiment 2), and infection was allowed to progress 37 h
(Expt 1) or 38 h (Expt 2). Cells were then transfected with luciferase constructs
containing no insert (empty vector pMiR-Report), or constructs containing inserts with
wild-type (WT) or mutated (Mut) portions of the LTV ICP4 gene. Plasmid pRL-CMV
(Renilla luciferase) was included in all samples as the transfection control. In both
experiments, at 7 h post-transfection, cells were assayed for ﬁreﬂy and Renilla luciferase
activities, and normalized luciferase values were calculated. Bars (±SE) are the average
of three biological replicates. Asterisks denote a signiﬁcant difference (pb0.05)
between the wild-type (WT) and mutant (Mut) target constructs.
29L.A. Waidner et al. / Virology 411 (2011) 25–31variation in processing and stability could produce different levels of
these microRNAs, as has been noted for other polycistronic micro-
RNAs (Sempere et al., 2004; Yao et al., 2008). A thorough analysis of
microRNA expression through lytic and latent cycles or an examina-
tion of relative microRNA abundances in latently infected tissues such
as trigeminal ganglia could provide additional insight into the
different roles of these two microRNAs.
An alternative explanation for the differential activity by iltv-miR-I5
and iltv-miR-I6 is the secondary structure of the target, as has been
suggested previously for C. elegans and human microRNAs (Long et al.,
2007; Obernosterer et al., 2008). We performed in silico folding of the
800-nucleotide region containing the targets for iltv-miR-I5 and iltv-
miR-I6. The secondary structure patterns in all possible foldings indicate
that the iltv-miR-I6 binding region lies within a well-protected stable
stem-loop, while the iltv-miR-I5 binding region is folded into a stem-
loop containing a predicted three-way structure (Supplemental Fig. 3).0.0
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the 300 nM or 600 nM negative control treatments.In the case of iltv-iltv-miR-I6 and others (Grey et al., 2007;Murphy et al.,
2008; Umbach et al., 2008), stable secondary structureswithin potential
target sites may preclude microRNA binding and subsequent target
downregulation (Obernosterer et al., 2008), whether it be via
translational repression or mRNA cleavage. Additionally, the introduc-
tion of cell-type-speciﬁc or sequence-speciﬁc cofactors could affect
microRNA function by blocking accessibility of the mRNA target
molecule (Bartel, 2009; Hobert, 2008).
MicroRNA regulation of ICP4 could impact the balance between
lytic and latent states, aid in maintaining latency of the virus in vivo, or
play a role in virus reactivation from latency. Our study adds to other
recent work that highlights the role of viral microRNAs in the
regulation of viral immediate early proteins. These data suggest that
iltv-miR-I5 could function in the regulation of latency by down-
regulation of targets through the siRNA slicing mechanism. The
differential effects of antisense microRNAs iltv-miR-I5 and iltv-miR-I6
in this study emphasize the likely importance of other factors, such as
target secondary structure, in microRNA-mediated mRNA cleavage.
Materials and methods
Cell cultures and viruses
The ILTVUSDAstrainwasobtained fromATCCand ismaintained in the
University of Delaware collection. The COS7 (Gluzman, 1981) and LMH
cell lines (Kawaguchi et al., 1987) were obtained from the University of
Georgia and University of Delaware collections. All cells were grown in
DMEM with 10% fetal bovine serum (FBS, Mediatech, Inc.) and 1%
penicillin–streptomycin–neomycin (PSN) antibiotic mixture (Invitrogen,
Inc.). LMH cells were plated on tissue culture vessels coated with 1%
porcine gelatin (Sigma).
Luciferase assays
COS7 cells were co-transfected with pMIR-REPORT™ vector
(Ambion, Inc.) constructs (pMiR-Report-I5-I6-target and its mutated
derivative, Fig. 1) and control pMIR-REPORT™ β-galactosidase
(Ambion) along with microRNA mimics (Ambion, Inc.) and antago-
miRs (Exiqon, Inc.). Negative control mimics from Ambion, Inc.
(AM17110) contained no known homology to the chicken genome.
Transfections were done in 96-well plates with Lipofectamine 2000
using the rapid transfection method according to the manufacturer's
instructions. Brieﬂy, 10,000 to 25,000 cells were mixed with nucleic
acid and lipid complexes, containing 8 ng/μl of each reporter plasmid
and either 300 nM or 600 nM mimics, and plated directly in DMEM
with 10% FBS and no antibiotics. Cells were allowed to attach and
replicate for 24–48 h. The Dual-Light® Combined Reporter Gene
Assay System (Invitrogen, Inc.) was used to determine relative levels
of β-galactosidase and ﬁreﬂy luciferase according to the manufac-
turer's instructions. Normalized ﬁreﬂy luciferase values were deter-
mined by addition of substrates and measurement of luminescence
for 0.1 s in a Wallac Victor3 plate reader (Perkin Elmer). Student's t-
test (two-tailed) was performed to compare treatment normalized
luciferase values to those of either 300 nM or 600 nM negative control
mimic treatments.
Luciferase assays in infected LMH cells
LMH cells were seeded in 96-well plates in DMEM supplemented
with 2% fetal bovine serum (FBS) and no antibiotics. Cells were
subsequently infected with ILTV USDA strain, at MOIs ranging from
0.16 or 0.22, and infection was allowed to progress 37–38 h. The
media was not removed prior to transfection, to ensure that virally
derived microRNAs and virus remained in the culture medium
throughout the course of the experiment. Cells were then transfected
with luciferase constructs containing no insert (pMiR-Report empty
Fig. 5.Modiﬁed 5′ RACE for the detection of iltv-miR-I5 cleavage products. A portion of the ICP4 coding region, which maps antisense to iltv-miR-I5-5p and iltv-miR-I5-3p, is shown
aligned with the microRNAs. The three positions of RACE cleavage fragments are indicated with grey highlighting and arrows, and the numbers of clones in parentheses and genome
positions are shown above the sequence.
30 L.A. Waidner et al. / Virology 411 (2011) 25–31vector), or constructs containing inserts of the portion of the ILTV ICP4
open reading frame complementary to the iltv-miR-I5 microRNA.
Inserts contained either the wild-type (WT) or mutated (Mut) seed
sequence complements (pmiR-Report-I5-Target, WT and Mut, Fig. 1).
Each treatment was also co-transfected with plasmid pRL-CMV
(Renilla luciferase, Promega) as the transfection control. Transfections
were done with Lipofectamine 2000 using the standard method
according to the manufacturer's instructions. Brieﬂy, nucleic acid and
lipid complexes were formed, containing 50 ng target plasmid, 50 ng
transfection control plasmid, and 0.25 μl Lipofectamine 2000 and
incomplete DMEM, for a total of in 50 μl for each well. After 45 min of
complex formation, the 50 μl complex mixture was overlaid on the
cell media (100 μl). At 7 h post-transfection, normalized luciferase
activity (ﬁreﬂy/Renilla luciferase) was determined using Dual-
Luciferase® Reporter (DLR™) assay system (Promega).
Quantitative RT-PCR
LMH cells were co-transfected in 6-well plates with microRNA
mimics and antagomiRs alongwith a plasmid expressing ICP4 (pRcICP4
(Fuchs et al., 2000)). Total RNA was extracted using Trizol (Invitrogen),
analyzed with a 2100 Bioanalyzer (Agilent), and subjected to DNAse
digestion prior to RT-PCR. qRT-PCR was performed using SYBR®
GreenER™ master mix with Superscript III enzyme mix (Invitrogen).
In control reactions, reverse transcriptase was omitted to conﬁrm the
absence of DNA in all samples. For some samples, a dilution series was
performed to conﬁrm the absence of PCR inhibitors in the RNA sample.
The efﬁciency of ampliﬁcation ranged from80% to 85% asdetermined by
the slope of the regression of RNAdilution versus threshold cycle values.
The calculation of normalized target mRNA relative to the endogenous
control (GAPDH) according to the delta-delta-CTwas done according to
the method described previously (Livak and Schmittgen, 2001). Using
this method, efﬁciencies of both target and endogenous mRNA
ampliﬁcations should be comparable, but need not be 100%, as long as
the efﬁciencies of the two transcripts compared within the experiment
are approximately equal. To test this, for each primer pair, we used the
target and endogenous delta-CT data from the dilution series of the RNA
samples, and all primer pairs met the criteria as outlined in this test.
All ICP4 RT-PCR reactions were normalized to chicken GAPDH, and
relative quantities (RQ, 2−ddCT) were calculated (Livak and Schmittgen,
2001). Chicken GAPDH was quantiﬁed using GAPDH-F and GAPDH-R
(Yang et al., 2007) with a ﬁnal concentration of 0.05 μM. Two regions of
ICP4 mRNA were ampliﬁed using primers described in Supplemental
Table 1, with a ﬁnal primer concentration of 0.05 μM. RQ values from
ICP4 ampliﬁcation were determined in samples treated withmicroRNA
mimics and antagomiRs, and these RQ values were compared to
treatments with 300 nM or 600 nM negative control mimics (Winer
et al., 1999). Student's t-test (two-tailed)was performed to compare RQ
of treatments to those of either 300 nM or 600 nM negative control
mimic treatments.
Modiﬁed RACE
LMH cells in four T75 ﬂasks were infected with ILTV USDA strain,
and RNA was harvested at 19 h post-infection. Total RNA was isolated
using the RNeasy RNA miniprep kit (Qiagen, Inc.), and mRNA wasisolated with the PolyATract® mRNA Isolation System (Promega).
PolyA-selected RNA was subjected to RT-PCR using primers for
cellular GAPDH (Yang et al., 2007) and ILTV glycoprotein C (Callison
et al., 2007) with and without reverse transcriptase to assess DNA
contamination. The ligation for the modiﬁed RACE used 1.2 μg mRNA
in a 20 μl ligation reaction containing 15 U T4 RNA ligase (Ambion,
Inc.) and the RNA oligonucleotide adapter (Dharmacon Research). The
ligated RNA was puriﬁed using an YM30 ultracentrifugation unit
(Amicon, Inc.), and 300 ng of the puriﬁed ligated RNAwas used in ﬁrst
strand synthesis using primer 4079R1 (Supplemental Table 1) and
Superscript II according to the manufacturer's instructions. Primary
and secondary PCRs contained primers as outlined in Supplemental
Table 1. The primary PCR (50 μl) contained 4 μl of the ﬁrst strand
reaction, and the secondary PCR (50 μl) contained 2–4 μl of the
primary PCR. PCR products were cloned directly into pCR2.1-TOPO
(Invitrogen) and sequenced using the M13 reverse primer.
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